Osaic Holdings’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Buy
107,099
+4,944
+5% +$15.8K ﹤0.01% 3624
2025
Q4
$279K Sell
102,155
-4,249
-4% -$9.83K ﹤0.01% 3876
2025
Q3
$237K Buy
106,404
+17,548
+20% +$41.4K ﹤0.01% 4073
2025
Q2
$154K Buy
88,856
+45,877
+107% +$114K ﹤0.01% 4151
2025
Q1
$143K Sell
42,979
-43,194
-50% -$223K ﹤0.01% 3909
2024
Q4
$636K Buy
86,173
+49,529
+135% +$459K ﹤0.01% 2569
2024
Q3
$344K Buy
36,644
+4,315
+13% +$40.9K ﹤0.01% 3205
2024
Q2
$259K Sell
32,329
-16,834
-34% -$180K ﹤0.01% 3327
2024
Q1
$729K Buy
49,163
+10,839
+28% +$126K ﹤0.01% 2624
2023
Q4
$311K Buy
38,324
+21,924
+134% +$115K ﹤0.01% 3573
2023
Q3
$74.6K Sell
16,400
-562
-3% -$3.67K ﹤0.01% 4726
2023
Q2
$119K Buy
16,962
+103
+0.6% +$737 ﹤0.01% 4293
2023
Q1
$103K Buy
16,859
+3
+0% +$21 ﹤0.01% 4427
2022
Q4
$107K Sell
16,856
-5,484
-25% -$42.8K ﹤0.01% 4374
2022
Q3
$214K Buy
22,340
+110
+0.5% +$1.27K ﹤0.01% 3673
2022
Q2
$245K Sell
22,230
-1,049
-5% -$13.7K ﹤0.01% 3589
2022
Q1
$388K Sell
23,279
-977
-4% -$15.1K ﹤0.01% 3470
2021
Q4
$463K Sell
24,256
-1,258
-5% -$27.7K ﹤0.01% 3142
2021
Q3
$628K Buy
25,514
+202
+0.8% +$4.76K ﹤0.01% 2801
2021
Q2
$659K Buy
25,312
+717
+3% +$18.6K ﹤0.01% 2729
2021
Q1
$779K Buy
24,595
+13,115
+114% +$544K ﹤0.01% 2445
2020
Q4
$533K Sell
11,480
-206
-2% -$8.18K ﹤0.01% 2585
2020
Q3
$380K Buy
11,686
+249
+2% +$7.63K ﹤0.01% 2685
2020
Q2
$314K Buy
11,437
+333
+3% +$10.9K ﹤0.01% 2733
2020
Q1
$332K Buy
+11,104
New +$294K ﹤0.01% 2437

Other funds holding IOVA